-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Recently, a research article was published in Diabetes, an authoritative journal in the field of diabetes .
Researchers aim to use two-way Mendelian randomization (MR) to study the relationship between blood sugar and cognitive function, brain structure, and dementia events
.
The data for this study comes from the British Biobank (n=500000)
.
The exposure factors of the study were genetic tools for type 2 diabetes (157 variants) and HbA1c (51 variants).
Through IVW, genetic susceptibility to type 2 diabetes and RT (index β=1.
00, 95%CI=1.
00; 1.
00), visual memory (VM) (expβ=1.
00, 95%CI=0.
99; 1.
00), white matter hyperintensity volume (WMHV) (expβ=0.
99, 95%CI=0.
97; 1.
01), hippocampal volume (HV) (β coefficient mm3=-2.
30, 95%CI=-12.
39;7.
78) or AD (OR=1.
15, 95%CI= 0.
87; 1.
52) irrelevant
.
HbA1c and RT (expβ=1.
00, 95%CI=0.
99; 1.
02), VM (expβ=0.
99, 95%CI=0.
96; 1.
02), WMHV (expβ=1.
03, 95%CI=0.
88; 1.
22), HV (β =-21.
31, 95%CI=-82.
96; 40.
34) or AD risk (OR 1.
09, 95%CI=0.
42; 2.
83) is irrelevant
.
After excluding a pleiotropic variant, IVW showed that RT was not associated with diabetes risk (OR 0.
Overall, the researchers did not observe evidence of a causal relationship between T2D or peripheral blood glucose genetic tools and middle-aged cognition and brain structure
Researchers have not observed evidence of a causal relationship between T2D or peripheral blood glucose genetic tools and middle-aged cognition and brain structure
Original source:
Original source:Victoria Garfield,et al.
The Relationship Between Glycaemia, Cognitive Function, Structural Brain Outcomes and Dementia: A Mendelian Randomisation Study in the UK Biobank in this message